Stoke Therapeutics Inc. (STOK)
Market Closed
17 Jul, 20:00
$
29. 05
-0.06
-0.2061%
$
1.95B Market Cap
- P/E Ratio
- Div Yield
414,000 Volume
-2.44 Eps
$ 29.11
Previous Close 
Want to track STOK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Stoke Therapeutics Inc. (STOK) Statistics
Valuation metrics
Market Cap 1.95B
Enterprise value 1.66B
Trailing P/E (ttm) -10.27
Forward P/E -11.21
PEG ratio -0.05
Price/Sales (ttm) 56.4
Price/Book (mrq) 4.64
Enterprise Value/Revenue 51.65
Enterprise Value/EBITDA -10.1
Overview
Shares outstanding 58.92M
Float 43.83M
Shares short 12.82M
% Held by insiders 0.04%
% Held by institutions 1.19%
Average volume (10 days) 670.33K
Average volume (90 days) 596.92K
Price summary
52-Week low 11.89
52-Week high 40.22
Beta 1.22
50-Day moving average 30.53
200-Day moving average 32.72
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -5.29%
Operating margin -5.77%
Operational effectiveness
Return on assets -0.38%
Return on equity -0.49%
Income Statement
Revenue (ttm) 184.42M
Revenue per share (ttm) 0.51
Quarterly revenue growth (yoy) -0.94%
Gross profit (ttm) 184.42M
EBITDA -18.82M
Net income to common (ttm) -6.88M
Diluted EPS (ttm) -2.69
Quarterly earnings growth (yoy) -0.94%
Balance Sheet
Total cash (mrq) 284.67M
Total cash per share (mrq) 5.45
Total debt (mrq) 4.15M
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 8.99%
Book value per share (mrq) 6.26
Cash Flow
Cash flow statement 45.59M
Levered free cash flow (LFCF) 33.02M
